Maintenance Niraparib Plus Ipilimumab in Patients With Metastatic Pancreatic Adenocarcinoma Whose Disease Has Not Progressed on Platinum-Based Chemotherapy
for Pancreatic Adenocarcinoma Metastatic
Drug: Ipilimumab
2 locations incl. Boston
Sponsor: Abramson Cancer Center at Penn Medicine
Sex: All·Age: 18+
Code: NCT06747845·Phase 2·Recruiting